Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis

Journal of Biological Chemistry

Volumn 289, Issue 12, 2014, Pages 8545-8561

  Ghatak, Shibnath ^a   Misra, Suniti ^a   Norris, Russell A ^a   Moreno Rodriguez, Ricardo A ^a   Hoffman, Stanley ^a   Levine, Robert A ^b   Hascall, Vincent C ^c   Markwald, Roger R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; ASSAYS; CELL DEATH; CELL SIGNALING; CHEMICAL ACTIVATION; COLLAGEN; ENZYME INHIBITION; MAMMALS; PIGMENTS; SIGNALING;

AUTOCRINE SIGNALING; COLLAGEN EXPRESSION; EXTRACELLULAR MATRICES; FUNCTIONAL ASSAYS; GENE TRANSFECTION; KINASE ACTIVATION; MATRICELLULAR PROTEIN; SIGNALING PATHWAYS;

HYALURONIC ACID;

BETA INTEGRIN; COLLAGEN TYPE 1; FOCAL ADHESION KINASE; HYALURONAN SYNTHASE 2; HYALURONIC ACID; INTEGRIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SYNTHETASE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATRIOVENTRICULAR VALVULOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; FIBROBLAST; GENETIC TRANSFECTION; IN VITRO STUDY; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ATRIOVENTRICULAR VALVE; CD44; CELL ADHESION; CELL MIGRATION; COLLAGEN; HYALURONATE; INTEGRINS; INTRACELLULAR KINASE SIGNALING; PERIOSTIN; PREVALVULAR CUSHION CELLS;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHICK EMBRYO; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE DELETION; HEART VALVES; HYALURONIC ACID; INTEGRINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SHEEP; SIGNAL TRANSDUCTION;

EID: 84896937123     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.539882     Document Type: Article

References (72)

1. Hamilton, D. W. (2008) Functional role of periostin in development and wound repair: implications for connective tissue disease. J. Cell Commun. Signal. 2, 9-17
2. Rios, H., Koushik, S. V., Wang, H., Wang, J., Zhou, H. M., Lindsley, A., Rogers, R., Chen, Z., Maeda, M., Kruzynska-Frejtag, A., Feng, J. Q., and Conway, S. J. (2005) Periostin-null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 25, 11131-11144 (Pubitemid 41747153)
3. Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., Brennan, F., and Foxwell, B. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774-780
4. Shinohara, M. L., Kim, J. H., Garcia, V. A., and Cantor, H. (2008) Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29, 68-78
5. Butcher, J. T., Norris, R. A., Hoffman, S., Mjaatvedt, C. H., and Markwald, R. R. (2007) Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev. Biol. 302, 256-266 (Pubitemid 46099041)
6. Conway, S. J., Izuhara, K., Kudo, Y., Litvin, J., Markwald, R., Ouyang, G., Arron, J. R., Holweg, C. T., and Kudo, A. (2013) The role of periostin in tissue remodeling across health and disease. Cell. Mol. Life Sci. 10.1007/s00018-013-1494-y
7. Norris, R. A., Borg, T. K., Butcher, J. T., Baudino, T. A., Banerjee, I., and Markwald, R. R. (2008) Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann. N.Y. Acad. Sci. 1123, 30-40 (Pubitemid 351431301)
8. Snider, P., Standley, K. N., Wang, J., Azhar, M., Doetschman, T., and Conway, S. J. (2009) Origin of cardiac fibroblasts and the role of periostin. Circ. Res. 105, 934-947
9. Souders, C. A., Bowers, S. L., and Baudino, T. A. (2009) Cardiac fibroblast: the renaissance cell. Circ. Res. 105, 1164-1176
10. Norris, R. A., Moreno-Rodriguez, R. A., Sugi, Y., Hoffman, S., Amos, J., Hart, M. M., Potts, J. D., Goodwin, R. L., and Markwald, R. R. (2008) Periostin regulates atrioventricular valve maturation. Dev. Biol. 316, 200-213
11. Norris, R. A., Moreno-Rodriguez, R., Hoffman, S., and Markwald, R. R. (2009) The many facets of the matricellular protein periostin during cardiac development, remodeling, and pathophysiology. J. Cell Commun. Signal. 3, 275-286
12. Doyle, A. J., Doyle, J. J., Bessling, S. L., Maragh, S., Lindsay, M. E., Schepers, D., Gillis, E., Mortier, G., Homfray, T., Sauls, K., Norris, R. A., Huso, N. D., Leahy, D., Mohr, D. W., Caulfield, M. J., Scott, A. F., Destrée, A., Hennekam, R. C., Arn, P. H., Curry, C. J., Van Laer, L., McCallion, A. S., Loeys, B. L., and Dietz, H. C. (2012) Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat. Genet. 44, 1249-1254
13. Tkatchenko, T. V., Moreno-Rodriguez, R. A., Conway, S. J., Molkentin, J. D., Markwald, R. R., and Tkatchenko, A. V. (2009) Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol. Genomics 39, 160-168
14. Kruzynska-Frejtag, A., Machnicki, M., Rogers, R., Markwald, R. R., and Conway, S. J. (2001) Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech. Dev. 103, 183-188 (Pubitemid 32457925)
15. Norris, R. A., Damon, B., Mironov, V., Kasyanov, V., Ramamurthi, A., Moreno-Rodriguez, R., Trusk, T., Potts, J. D., Goodwin, R. L., Davis, J., Hoffman, S., Wen, X., Sugi, Y., Kern, C. B., Mjaatvedt, C. H., Turner, D. K., Oka, T., Conway, S. J., Molkentin, J. D., Forgacs, G., and Markwald, R. R. (2007) Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J. Cell. Biochem. 101, 695-711 (Pubitemid 46698854)
16. Li, G., Jin, R., Norris, R. A., Zhang, L., Yu, S., Wu, F., Markwald, R. R., Nanda, A., Conway, S. J., Smyth, S. S., and Granger, D. N. (2010) Periostin mediates vascular smooth muscle cell migration through the integrins αvβ3 αvβ5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 208, 358-365
17. Orecchia, P., Conte, R., Balza, E., Castellani, P., Borsi, L., Zardi, L., Mingari, M. C., and Carnemolla, B. (2011) Identification of a novel cell binding site of periostin involved in tumour growth. Eur. J. Cancer 47, 2221-2229
18. Paranya, G., Vineberg, S., Dvorin, E., Kaushal, S., Roth, S. J., Rabkin, E., Schoen, F. J., and Bischoff, J. (2001) Aortic valve endothelial cells undergo transforming growth factor-β-mediated and non-transforming growth factor-β-mediated transdifferentiation in vitro. Am. J. Pathol. 159, 1335-1343 (Pubitemid 32947963)
19. Misra, S., Ghatak, S., Patil, N., Dandawate, P., Ambike, V., Adsule, S., Unni, D., Venkateswara Swamy, K., and Padhye, S. (2013) Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells. Bioorg. Med. Chem. 21, 2551-2559
20. Misra, S., Ghatak, S., and Toole, B. P. (2005) Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J. Biol. Chem. 280, 20310-20315 (Pubitemid 40776728)
21. Misra, S., Ghatak, S., Zoltan-Jones, A., and Toole, B. P. (2003) Regulation of multidrug resistance in cancer cells by hyaluronan. J. Biol. Chem. 278, 25285-25288 (Pubitemid 36835275)
22. Misra, S., Hascall, V. C., De Giovanni, C., Markwald, R. R., and Ghatak, S. (2009) Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ mice. J. Biol. Chem. 284, 12432-12446
23. Misra, S., Obeid, L. M., Hannun, Y. A., Minamisawa, S., Berger, F. G., Markwald, R. R., Toole, B. P., and Ghatak, S. (2008) Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J. Biol. Chem. 283, 14335-14344
24. Misra, S., Toole, B. P., and Ghatak, S. (2006) Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J. Biol. Chem. 281, 34936-34941 (Pubitemid 46036532)
25. Ghatak, S., Hascall, V. C., Markwald, R. R., and Misra, S. (2010) Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J. Biol. Chem. 285, 19821-19832
26. Ghatak, S., Misra, S., and Toole, B. P. (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem. 277, 38013-38020 (Pubitemid 35154652)
27. Ghatak, S., Misra, S., and Toole, B. P. (2005) Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol. Chem. 280, 8875-8883 (Pubitemid 40409577)
28. Misra, S., Hascall, V. C., Berger, F. G., Markwald, R. R., and Ghatak, S. (2008) Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer. Connect. Tissue Res. 49, 219-224
29. Calve, S., Isaac, J., Gumucio, J. P., and Mendias, C. L. (2012) Hyaluronic acid, HAS1, and HAS2 are significantly upregulated during muscle hypertrophy. Am. J. Physiol. Cell Physiol. 303, C577-C588
30. Yang, L., Serada, S., Fujimoto, M., Terao, M., Kotobuki, Y., Kitaba, S., Matsui, S., Kudo, A., Naka, T., Murota, H., and Katayama, I. (2012) Periostin facilitates skin sclerosis via PI3K/Akt-dependent mechanism in a mouse model of scleroderma. PLoS ONE 7, e41994
31. Shi-Wen, X., Chen, Y., Denton, C. P., Eastwood, M., Renzoni, E. A., Bou-Gharios, G., Pearson, J. D., Dashwood, M., du Bois, R. M., Black, C. M., Leask, A., and Abraham, D. J. (2004) Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol. Biol. Cell 15, 2707-2719 (Pubitemid 38691860)
32. Norris, R. A., Potts, J. D., Yost, M. J., Junor, L., Brooks, T., Tan, H., Hoffman, S., Hart, M. M., Kern, M. J., Damon, B., Markwald, R. R., and Goodwin, R. L. (2009) Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev. Dyn. 238, 1052-1063
33. Mitra, S. K., Hanson, D. A., and Schlaepfer, D. D. (2005) Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56-68 (Pubitemid 40064899)
34. Stambolic, V., and Woodgett, J. R. (2006) Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol. 16, 461-466 (Pubitemid 44293397)
35. Gabarra-Niecko, V., Keely, P. J., and Schaller, M. D. (2002) Characterization of an activated mutant of focal adhesion kinase: 'SuperFAK'. Biochem. J. 365, 591-603 (Pubitemid 34864441)
36. Downward, J. (1994) The GRB2/Sem-5 adaptor protein. FEBS Lett. 338, 113-117
37. Eide, B. L., Turck, C. W., and Escobedo, J. A. (1995) Identification of Tyr-397 as the primary site of tyrosine phosphorylation and pp60src association in the focal adhesion kinase, pp125FAK. Mol. Cell. Biol. 15, 2819-2827
38. Chen, H. C., Appeddu, P. A., Isoda, H., and Guan, J. L. (1996) Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271, 26329-26334 (Pubitemid 26347485)
39. Ebi, H., Costa, C., Faber, A. C., Nishtala, M., Kotani, H., Juric, D., Della Pelle, P., Song, Y., Yano, S., Mino-Kenudson, M., Benes, C. H., and Engelman, J. A. (2013) PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proc. Natl. Acad. Sci. U.S.A. 110, 21112-21129
40. Eisenberg, L. M., and Markwald, R. R. (1995) Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77, 1-6
41. Person, A. D., Klewer, S. E., and Runyan, R. B. (2005) Cell biology of cardiac cushion development. Int. Rev. Cytol. 243, 287-335 (Pubitemid 41557302)
42. Kruithof, B. P., Krawitz, S. A., and Gaussin, V. (2007) Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev. Biol. 302, 208-217 (Pubitemid 46099040)
43. Kumar, C. C. (1998) Signaling by integrin receptors. Oncogene 17, 1365-1373
44. Todorovic, V., Finnegan, E., Freyer, L., Zilberberg, L., Ota, M., and Rifkin, D. B. (2011) Long form of latent TGF-β binding protein 1 (Ltbp1L) regulates cardiac valve development. Dev Dyn. 240, 176-187
45. Camenisch, T. D., Spicer, A. P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M. L., Calabro, A., Jr., Kubalak, S., Klewer, S. E., and McDonald, J. A. (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106, 349-360 (Pubitemid 30655635)
46. Hayashida, T., Decaestecker, M., and Schnaper, H. W. (2003) Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J. 17, 1576-1578
47. Hayashida, T., Poncelet, A. C., Hubchak, S. C., and Schnaper, H. W. (1999) TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 56, 1710-1720 (Pubitemid 29518171)
48. Gayer, C. P., Chaturvedi, L. S., Wang, S., Craig, D. H., Flanigan, T., and Basson, M. D. (2009) Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway. J. Biol. Chem. 284, 2001-2011
49. Leask, A., and Abraham, D. J. (2004) TGF-β signaling and the fibrotic response. FASEB J. 18, 816-827
50. Kim, H., Sengupta, A., Glogauer, M., and McCulloch, C. A. (2008) Filamin A regulates cell spreading and survival via β1 integrins. Exp. Cell Res. 314, 834-846
51. Kyndt, F., Gueffet, J. P., Probst, V., Jaafar, P., Legendre, A., Le Bouffant, F., Toquet, C., Roy, E., McGregor, L., Lynch, S. A., Newbury-Ecob, R., Tran, V., Young, I., Trochu, J. N., Le Marec, H., and Schott, J. J. (2007) Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 115, 40-49 (Pubitemid 46058610)
52. Kyndt, F., Schott, J. J., Trochu, J. N., Baranger, F., Herbert, O., Scott, V., Fressinaud, E., David, A., Moisan, J. P., Bouhour, J. B., Le Marec, H., and Bénichou, B. (1998) Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am. J. Hum. Genet. 62, 627-632 (Pubitemid 28164620)
53. Norris, R. A., Moreno-Rodriguez, R., Wessels, A., Merot, J., Bruneval, P., Chester, A. H., Yacoub, M. H., Hagège, A., Slaugenhaupt, S. A., Aikawa, E., Schott, J. J., Lardeux, A., Harris, B. S., Williams, L. K., Richards, A., Levine, R. A., and Markwald, R. R. (2010) Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. Dev. Dyn. 239, 2118-2127
54. Lardeux, A., Kyndt, F., Lecointe, S., Marec, H. L., Merot, J., Schott, J. J., Le Tourneau, T., and Probst, V. (2011) Filamin-A-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects. J. Cardiovasc. Transl. Res. 4, 748-756
55. Kyndt, F., Le Scouarnec, S., Jaafar, P., Gueffet, J. P., Legendre, A., Trochu, J. N., Jousseaume, V., Chaventré, A., Schott, J. J., Le Marec, H., and Probst, V. (2007) Genetic aspects of valvulopathies. Arch. Mal. Coeur Vaiss. 100, 1013-1020 (Pubitemid 351182906)
56. Lesley, J., English, N., Charles, C., and Hyman, R. (2000) The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. Eur. J. Immunol. 30, 245-253 (Pubitemid 30011786)
57. Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., Saito, M., Fukuda, K., Nishiyama, T., Kitajima, S., Saga, Y., Fukayama, M., Sata, M., and Kudo, A. (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 205, 295-303 (Pubitemid 351281595)
58. Mjaatvedt, C. H., Yamamura, H., Capehart, A. A., Turner, D., and Markwald, R. R. (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 202, 56-66 (Pubitemid 28467247)
59. Vigetti, D., Viola, M., Karousou, E., De Luca, G., and Passi, A. (2013) Metabolic control of hyaluronan synthases. Matrix Biol. 10.1016/j. matbio.2013.10.002
60. Vigetti, D., Genasetti, A., Karousou, E., Viola, M., Clerici, M., Bartolini, B., Moretto, P., De Luca, G., Hascall, V. C., and Passi, A. (2009) Modulation of hyaluronan synthase activity in cellular membrane fractions. J. Biol. Chem. 284, 30684-30694
61. Hardie, D. G. (2004) The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 117, 5479-5487
62. Towler, M. C., and Hardie, D. G. (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100, 328-341
63. Camenisch, T. D., Schroeder, J. A., Bradley, J., Klewer, S. E., and McDonald, J. A. (2002) Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat. Med. 8, 850-855
64. Bourguignon, L. Y., Gilad, E., and Peyrollier, K. (2007) Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J. Biol. Chem. 282, 19426-19441 (Pubitemid 47100114)
65. Snider, P., Hinton, R. B., Moreno-Rodriguez, R. A., Wang, J., Rogers, R., Lindsley, A., Li, F., Ingram, D. A., Menick, D., Field, L., Firulli, A. B., Molkentin, J. D., Markwald, R., and Conway, S. J. (2008) Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 102, 752-760 (Pubitemid 351521582)
66. Kallergi, G., Mavroudis, D., Georgoulias, V., and Stournaras, C. (2007) Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells. Mol. Med. 13, 79-88 (Pubitemid 46786836)
67. Bourguignon, L. Y. (2008) Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin. Cancer Biol. 18, 251-259
68. Duval, D., Lardeux, A., Le Tourneau, T., Norris, R. A., Markwald, R. R., Sauzeau, V., Probst, V., Le Marec, H., Levine, R., Schott, J. J., and Merot, J. (2014) Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation. Biochim. Biophys. Acta 1843, 234-244
69. McDonald, J., and Hascall, V. C. (2002) Hyaluronan minireview series. J. Biol. Chem. 277, 4575-4579 (Pubitemid 34968481)
70. Vigetti, D., Clerici, M., Deleonibus, S., Karousou, E., Viola, M., Moretto, P., Heldin, P., Hascall, V. C., De Luca, G., and Passi, A. (2011) Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J. Biol. Chem. 286, 7917-7924
71. Bandyopadhyay, S. K., de la Motte, C. A., Majors, A. K., and Strong, S. A. (2010) Inhibition of the phosphatidylinositol-3-kinase pathway abrogates polyinosinic:polycytidylic acid-stimulated hyaluronan-mediated human mucosal smooth muscle cell binding of U937 monocytic cells. J. Interferon Cytokine Res. 30, 809-816
72. Hascall, V. C., Wang, A., Tammi, M., Oikari, S., Tammi, R., Passi, A., Vigetti, D., Hanson, R. W, and Hart, G. W. (2014) The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. Matrix Biol. 10.1016/j.matbio.2014.01.014